bathocuproine disulfonate has been researched along with bathophenanthroline in 1 studies
| Studies (bathocuproine disulfonate) | Trials (bathocuproine disulfonate) | Recent Studies (post-2010) (bathocuproine disulfonate) | Studies (bathophenanthroline) | Trials (bathophenanthroline) | Recent Studies (post-2010) (bathophenanthroline) |
|---|---|---|---|---|---|
| 103 | 0 | 25 | 77 | 1 | 23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnham, KJ; Beyreuther, K; Bush, AI; Cherny, RA; Li, QX; Lynch, T; Masters, CL; McLean, CA; Multhaup, G; Tanzi, RE; Volitakis, I | 1 |
1 other study(ies) available for bathocuproine disulfonate and bathophenanthroline
| Article | Year |
|---|---|
Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Chelating Agents; Copper; Humans; Mice; Mice, Transgenic; Nuclear Magnetic Resonance, Biomolecular; Penicillamine; Peptides; Phenanthrolines; Pilot Projects; Solubility; Trientine; Zinc | 2000 |